A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)
Clinical trial NCT01477853 · TERMINATED
Trial details
- NCT number
- NCT01477853
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-24
- Primary completion
- 2012-12-04
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.